Bionor Pharma to initiate HIV Vacc-4x combination trial
Bionor Pharma is set to initiate a double blinded, randomized and placebo-controlled trial to evaluate...
Scancell updates on cancer vaccine Phase I clinical trial
The Cohort Review Committee has approved Scancell to further escalate cancer vaccine SCIB1 dose to...
Aeras, OETC commence TB drug Phase IIb trial
Aeras and the Oxford-Emergent Tuberculosis Consortium (OETC) have commenced a Phase IIb trial to investigate...
Alnylam concludes liver cancer drug Phase I trial
US based drug developer Alnylam Pharmaceuticals has concluded an open label, multi-center, dose escalation Phase...
Sinapis Pharma concludes Phase I stroke drug trial
Sinapis Pharma has concluded first Phase I clinical trial of oral and IV administration of...
Phase 3 Study of YERVOY Metastatic Melanoma Meets Primary Endpoint of Overall Survival
Bristol-Myers Squibb Company announced results from a second Phase 3 randomized, double blind study demonstrating...
Roche announces data to show Avastin based regimen halved the risk of disease getting...
Roche announced results from OCEANS, a phase III study evaluating Avastin (bevacizumab) in combination with...
Adaptimmune announces Opening of Phase I/II Clinical Trial in Multiple Myeloma
Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial...
First ever study to apply therapeutic approach of global immune reconstitution to treatment of...
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies...
FDA approves linagliptin tablets for the treatment of type 2 diabetes
Boehringer Ingelheim and Eli Lilly and Company announced that the U.S. Food and Drug Administration...